ライフサイエンスコーパス: endometrial hyperplasia

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 nths of age, the absence of Mig-6 results in endometrial hyperplasia.

2 ma, prostatic intraepithelial neoplasia, and endometrial hyperplasia.

3 ortant, since unexpected bleeding may signal endometrial hyperplasia.

4 the mechanism by which tamoxifen results in endometrial hyperplasia.

5 accompanied by an unacceptably high rate of endometrial hyperplasia.

6 ocrine therapy and reduces tamoxifen-induced endometrial hyperplasia, a strategy with potential clini

7 and was restricted primarily to the atypical endometrial hyperplasia (AEH) type with coexisting endom

8 measure was endometrial cancer and atypical endometrial hyperplasia (AEH).

9 lost in a high percentage of cases of human endometrial hyperplasia and adenocarcinoma, which are li

10 and phosphorylated ER-alpha was increased in endometrial hyperplasia and atypical hyperplasia compare

11 to female reproductive disorders, including endometrial hyperplasia and breast cancer.

12 cated as a mediator of the increased risk of endometrial hyperplasia and cancer resulting from the us

13 Cables mutant mice are viable, but develop endometrial hyperplasia and carcinoma in situ at a young

14 important implications for the treatment of endometrial hyperplasia and carcinoma in women.

15 osity in stromal APC is sufficient to induce endometrial hyperplasia and endometrial carcinogenesis b

16 e cellular proliferation in vivo in atypical endometrial hyperplasia and endometrial endometrioid ade

17 Wnt7a(cre+)Mig-6(f/f) mice developed endometrial hyperplasia and estrogen-dependent endometri

18 he murine uterus leads to the development of endometrial hyperplasia and estrogen-induced endometrial

19 Our findings show that in endometrial hyperplasia and low-grade EEC, coordinate in

20 oxifen include vaginal endometrial bleeding, endometrial hyperplasia, and cancer, conditions associat

21 esions allowed us to exclude polyps, but not endometrial hyperplasias, as potential precancers.

22 ession on a TMA, including a large series of endometrial hyperplasia, atypical hyperplasia, and adeno

23 8.9% of Pten(+/-)ERalpha(-/-) mice developed endometrial hyperplasia/carcinoma.

24 Female mutant mice develop endometrial hyperplasia due to aberrant phosphorylation

25 nt in endometrial tumorigenesis we evaluated endometrial hyperplasia (EH) characterized as simple, co

26 en and progesterone bear on the incidence of endometrial hyperplasia (EH), a noninvasive proliferatio

27 PURPOSE The severity of endometrial hyperplasia (EH)-simple (SH), complex (CH),

28 etrial carcinoma and its precursor, atypical endometrial hyperplasia (EH).

29 able evidence that tamoxifen can also induce endometrial hyperplasia in pre menopausal women.

30 These females develop atypical endometrial hyperplasia of which approximately 20% progr

31 omplex structures, such as those observed in endometrial hyperplasia or carcinoma.

32 ogy clinics in Manchester, UK, with atypical endometrial hyperplasia or endometrial endometrioid aden

33 may present with vaginal bleeding caused by endometrial hyperplasia or uterine cancer as a result of

34 R+ putative endometrial precancers (atypical endometrial hyperplasias) progress to RER+ carcinomas, w

35 ovarian and endometrial tumors as well as in endometrial hyperplasia, signifying the importance of PR

36 Endometrial cancer is preceded by endometrial hyperplasia, unopposed estrogen exposure, an

37 Genomic DNA from 51 endometrial hyperplasias was extracted from paraffin blo

38 plasms of uncertain malignant potential, and endometrial hyperplasia were estimated.

39 tumors of uncertain malignant potential, or endometrial hyperplasia) were 0.67% (n = 257) (95% CI, 0

40 carcinoma, endometrial polyps, and atypical endometrial hyperplasias, whereas normal and anovulatory

41 e whether PTEN mutations also are present in endometrial hyperplasias, which are premalignant precurs

42 ved human specimens of normal endometrium; 7 endometrial hyperplasia with or without atypia; 32 endom

43 was no higher frequency of PTEN mutations in endometrial hyperplasias with atypia (6 of 32; 19%) rela

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。